Representative before the EPO

Technology company logo thumb
operating until 2007
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

We have observed 4 EP applications Frank Dressen has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after August 18, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11779451

PROCESS FOR PREPARING LACOSAMIDE

IPC classification:
C07C 233/47, C07C 229/22, C07C 237/22
Applicant:
UCB Pharma GmbH
Agent:
Frank Dressen, UCB Pharma GmbH
Agent:
John Thompson, UCB Celltech
Status:
GRANT OF PATENT INTENDED
EP13004798

Pharmaceutical composition comprising lacosamide and levetiracetam for use in the treatment of epilepsy

IPC classification:
A61K 38/04, A61K 31/4015, A61K 31/40, A61K 31/165, A61P 25/14, A61P 25/08, A61P 21/00, A61P 19/00
Applicant:
UCB Pharma GmbH
Agent:
Hoffmann Eitle PartmbB
Agent:
Frank Dressen, UCB Pharma GmbH
Status:
PATENT GRANTED
EP13005561

Pharmaceutical composition comprising lacosamide and levetiracetam

IPC classification:
A61K 31/4015, A61K 31/165, A61P 25/08
Applicant:
UCB Pharma GmbH
Agent:
Frank Dressen, UCB Pharma GmbH
Status:
APPLICATION REFUSED
EP15156237

PHARMACEUTICAL COMPOSITION COMPRISING BRIVARACETAM AND LACOSAMIDE WITH SYNERGISTIC ANTICONVULSANT EFFECT

IPC classification:
A61P 25/08, A61K 31/4015, A61K 38/04
Applicant:
UCB Pharma GmbH
Agent:
Frank Dressen, UCB Pharma GmbH
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature